Alexis Peyroles

Directeur/Membre du Conseil chez OSE IMMUNOTHERAPEUTICS

Fortune : 640 301 $ au 31/10/2026

Health Technology

Consumer Services

Distribution Services

Profil

Mr. Alexis Peyroles is an Independent Director at OSE Immunotherapeutics SA, a Chief Executive Officer & Director at Betaglue Technologies SpA, a Chairman & Chief Financial Officer at Inside Therapeutics SAS, a Chairman at Aperana Consulting SAS and a Chief Executive Officer at OSE Immunotherapeutics, Inc. He is on the Board of Directors at OSE Immunotherapeutics SA and Betaglue Technologies SpA. Mr. Peyroles was previously employed as a CFO & Head-Business Development by Orphan Synergy Europe-Pharma SA, a Chief Executive Officer by Guerbet Imagem do Brasil Ltda., a Manager-Financial Control by Guerbet SA, a Head-Eastern Europe Business Development by Sanofi-Aventis France SA, and a Head-Financial Control-Baltic States by Sanofi-Aventis Japan.
He received his undergraduate degree from École des Hautes Études Commerciales du Nord and an MBA from Imperial College Business School.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
OSE IMMUNOTHERAPEUTICS SA 1,25%	30/09/2025	293 848 ( 1,25% )	640 301 $	31/10/2026

Postes actifs de Alexis Peyroles

Sociétés	Poste	Début
OSE IMMUNOTHERAPEUTICS	Directeur/Membre du Conseil	30/09/2025
Ose Immunotherapeutics, Inc.	Directeur Général	-
Betaglue Technologies SpA Betaglue Technologies SpA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company that manufacture oncology therapeutic products	Directeur Général	22/09/2025
Aperana Consulting SAS	Président	-

Tous les postes actifs de Alexis Peyroles

Anciens postes connus de Alexis Peyroles

Sociétés	Poste	Fin
OSE IMMUNOTHERAPEUTICS	Directeur Général	16/01/2022
Sanofi-Aventis Japan	Comptroller/Controller/Auditor	-
GUERBET	Comptroller/Controller/Auditor	-
Sanofi-Aventis France SA Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products	Corporate Officer/Principal	-
Orphan Synergy Europe-Pharma SA Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers	Directeur Financier/CFO	-

Voir l'expérience en détail de Alexis Peyroles

Formation de Alexis Peyroles

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Alexis Peyroles

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	11
Guerbet SA Guerbet SA Medical SpecialtiesHealth Technology Engages in research, development and production of X-Rays and its by products	Health Technology
Sanofi-Aventis Japan
École des Hautes Études Commerciales du Nord École des Hautes Études Commerciales du Nord Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sanofi-Aventis France SA Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products	Distribution Services
Orphan Synergy Europe-Pharma SA Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers	Health Technology
Imperial College Business School Imperial College Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Aperana Consulting SAS
OSE Immunotherapeutics SA OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers	Health Technology
Betaglue Technologies SpA Betaglue Technologies SpA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company that manufacture oncology therapeutic products	Commercial Services
Ose Immunotherapeutics, Inc.
Guerbet Imagem do Brasil Ltda.